Rephonic
Artwork for Business Of Biotech

Business Of Biotech

Ben Comer
Clinical Trials
Biotechnology
FDA
Drug Development
Gene Therapy
Biotech
Oncology
Pharmaceutical Industry
Covid-19
Cell and Gene Therapy
Psychedelics
Artificial Intelligence
Biopharma
Biologics
Radiopharmaceuticals
MRNA
Bit.bio
XOMA Royalty
Biopharmaceuticals
Obesity

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest c... more

PublishesWeeklyEpisodes332Founded7 years ago
Number of ListenersCategories
ManagementBusinessLife SciencesScience

Listen to this Podcast

Artwork for Business Of Biotech

Latest Episodes

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Sean Kelley, Vice President for neuroscience and toxins, Portfolio Strategy and Program Leadership at AbbVie, talks through the development fa... more

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Edward (Ned) Patz, M.D., Cofounder and CEO at Grid Therapeutics, explains how a Duke University lab discovery turned into Grid Therapeutics an... more

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Keith Murphy, CEO at Viscient Biosciences, unpacks how 3D human tissue models and scaffold-free bioprinting can change the way developers pred... more

YouTube

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about his path from medical geneticist to CNS drug development ... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Edward Patz
Physician-scientist, cofounder and CEO of Grid Therapeutics
Grid Therapeutics
Episode: Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.
Keith Murphy
Biotech entrepreneur and CEO of Viscient Biosciences, founder of Organovo
Viscient Biosciences
Episode: Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy
Bret Bostwick
Physician-scientist, board-certified medical geneticist and venture partner
Breyer Capital
Episode: Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.
Simeon George
CEO and co-founder of SR One Capital Management
SR One Capital Management
Episode: AI, China, And Biotech Investing With SR One's Simeon George, M.D.
Cyriac Roeding
CEO and co-founder of Earli, investor and tech entrepreneur
Earli, Roeding Ventures
Episode: Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding
Philina Lee
CEO at AdvanCell
AdvanCell
Episode: Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D.
Alex Aravanis
CEO of Moonwalk Biosciences
Moonwalk Biosciences
Episode: Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D.
Allan Shaw
Independent Director at Avexia Therapeutics and Calce Medica; former CFO and board member
Avexia Therapeutics; Calce Medica
Episode: Biotech Finance And Investor Update With Independent Board Director Allan Shaw
David Craig
Co-Founder, President and CEO at Sarcomatrix
Sarcomatrix
Episode: Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig

Host

Ben Comer
Chief editor at Life Science Leader

Reviews

4.6 out of 5 stars from 176 ratings
  • great interview with bit.bio

    Enjoyed your latest episode with bit.bio’s Mark Kotter!

    Apple Podcasts
    5
    ladyscientistpodcast
    United States3 years ago
  • Timely news & interesting guests

    A great way to stay up to date with all that is happening in the biotech world. Lively discussions as the host Matt has unfiltered chats with top industry icons. Best podcast I’ve found in this field!

    Apple Podcasts
    5
    Boddiingsytikgd
    United States3 years ago
  • Great Show!

    Very insightful! Matt's a great host, he knows what questions to ask his guests. A great podcast for latest trends in Biotech and Pharmacy industry!

    Apple Podcasts
    5
    Retchelle_Platforce
    Philippines4 years ago
  • Episodes are great, Newsletter no no no

    I learn so much every episode. The recent episode featuring Recursion was especially helpful.

    The only annoying thing, I signed up for the newsletter after all the talk about it not being “another newsletter” but it’s actually worse than most. WAY too many headlines, poor formatting makes it hard to follow or focus on any particular one, the thing is poorly designed and packed with jargon.

    Apple Podcasts
    5
    Glleee
    United States4 years ago
  • A+ episodes, every time!

    What better way to keep up with the latest in the world of biotech than to hear directly from leaders and innovators shaping the landscape? Engaging conversations, knowledgeable guests, and insights into the industry abound. Don't miss it!

    Apple Podcasts
    5
    Arlie K
    United States4 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The interviews are described as conversational, engaging and well paced, with hosts who ask informed questions and keep discussions focused.
One listener criticizes the newsletter's formatting and volume of headlines, while praising the episode content.
Listeners value the access to biotech leaders and their firsthand perspectives on company strategy, drug development and industry trends.
Some listeners find the content useful but want more depth on bioscience or the practical mechanics of running a biotech company.
Listeners say the conversations offer useful context for both experienced industry professionals and people new to biotech.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.
Q: What makes GT103 and complement factor H a unique approach to targeting cancer?
Patz says the antibody recognizes a tumor-associated cryptic epitope of Complement Factor H and can bind differently to tumor cells than to normal cells. He describes its potential to kill tumor cells and activate an adaptive immune response, while noting early clinical results and the need to establish which patients may benefit.
Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.
Q: Can you give me a sense of when that happened? And then, I guess, what prompted you to decide, hey, we need to, like, found a biotech company to develop this and make it available to patients?
Patz explains that research into metastasis and biomarkers led his team to find antibodies in some early-stage, non-metastatic patients. After identifying the antibody and its target, he wanted to translate the discovery into treatment for patients. When potential partners would not license the novel target and antibody, the team created Grid Therapeutics to continue development.
Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy
Q: Are there new policies you would like to see the FDA introduce to help accelerate the transition to new approach methodologies?
Murphy says drug candidates should receive human-cell liver toxicity screening before phase one and recommends combining NAMs with animal models where each adds value. He also suggests incentives such as a lottery entry for a priority review voucher when companies include NAM data in filings.
Bioprinting 3D Human Tissue To Discover And Test New Treatments With Viscient Bio's Keith Murphy
Q: How does a 3D bioprinted human tissue model compare with a rodent model?
Murphy says primary human cells can preserve disease characteristics more directly than experimentally induced animal disease models, while human tissue models can reveal toxicity that animals may miss. He sees the approaches as complementary, with human models potentially identifying risks earlier and reducing some animal studies.
Investing In Tomorrow's CNS Breakthroughs With Breyer Capital's Bret Bostwick, M.D.
Q: What are the most promising and most overblown uses of AI in early-stage biotech?
AI can improve molecule design and help build preclinical packages, but generating huge numbers of compounds does not solve the bigger challenge of clinical development. Bostwick sees compressing clinical trials and biomedical timelines as a more important opportunity.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Business Of Biotech

What is Business Of Biotech about and what kind of topics does it cover?

Conversations with founders, executives, investors and other leaders on the business challenges of building emerging biopharma companies. Hosted by Ben Comer, the interviews connect scientific programs with the decisions required to fund, develop, manufacture, regulate and commercialize therapies. Topics range from drug discovery and clinical development to venture financing, company formation, manufacturing capacity, market access and partnerships.

Guests bring firsthand experience from biotech companies, investment firms, foundations and academic institutions. Discussions pair technical context on therapeutic approaches and development risks with practical perspectives on leadership, capital strategy and company growth. The focus on how ... more

Where can I find podcast stats for Business Of Biotech?

Rephonic provides a wide range of podcast stats for Business Of Biotech. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Business Of Biotech and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Business Of Biotech get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Business Of Biotech, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Business Of Biotech?

Rephonic provides comprehensive predictive audience data for Business Of Biotech, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Business Of Biotech have?

To see how many followers or subscribers Business Of Biotech has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Business Of Biotech?

These podcasts share a similar audience with Business Of Biotech:

1. BioCentury This Week
2. Biotech Hangout
3. The Readout Loud
4. The Long Run with Luke Timmerman
5. Biotech 2050 Podcast

How many episodes of Business Of Biotech are there?

Business Of Biotech launched 7 years ago and published 332 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Business Of Biotech?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Business Of Biotech?

Rephonic pulls ratings and reviews for Business Of Biotech from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Business Of Biotech?

Rephonic provides full transcripts for episodes of Business Of Biotech. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Business Of Biotech?

Recent guests on Business Of Biotech include:

1. Edward Patz
2. Keith Murphy
3. Bret Bostwick
4. Simeon George
5. Cyriac Roeding
6. Philina Lee
7. Alex Aravanis
8. Allan Shaw

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days